The Toronto-based startup is applying AI to ultrasound signals. It differentiates healthy tissue from diseased tissue by measuring its acoustic properties.
Focused ultrasound, essentially concentrated sound waves, have been used in early-stage clinical trials to temporarily disrupt the blood-brain barrier, creating a window of time where a therapeutic treatment could be delivered in a targeted manner. The potential impact of this advancement is enormous.
Focused ultrasound, a rarely used treatment that involves zapping a body part with converging beams of sound, has gotten the attention of Joe Biden and the moonshot initiative.
